Human Cdc34 and Rad6B ubiquitin-conjugating enzymes target repressors of cyclic AMP-induced transcription for proteolysis
about
ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligaseThe bZIP transcription factor ATFx binds human T-cell leukemia virus type 1 (HTLV-1) Tax and represses HTLV-1 long terminal repeat-mediated transcriptionNucleophosmin (NPM1/B23) interacts with activating transcription factor 5 (ATF5) protein and promotes proteasome- and caspase-dependent ATF5 degradation in hepatocellular carcinoma cellsA handcuff model for the cohesin complexThe GABAB receptor interacts directly with the related transcription factors CREB2 and ATFxUbiquitin charging of human class III ubiquitin-conjugating enzymes triggers their nuclear importFunctional and phylogenetic analysis of the ubiquitylation system in Caenorhabditis elegans: ubiquitin-conjugating enzymes, ubiquitin-activating enzymes, and ubiquitin-like proteinsFunctions of the DNA damage response pathway target Ho endonuclease of yeast for degradation via the ubiquitin-26S proteasome systemPhosphorylation of the human ubiquitin-conjugating enzyme, CDC34, by casein kinase 2HSP70 protein promotes survival of C6 and U87 glioma cells by inhibition of ATF5 degradationIdentification of a novel DNA binding site and a transcriptional target for activating transcription factor 5 in c6 glioma and mcf-7 breast cancer cellsInhibition of apoptosis by ATFx: a novel role for a member of the ATF/CREB family of mammalian bZIP transcription factorsElevating the level of Cdc34/Ubc3 ubiquitin-conjugating enzyme in mitosis inhibits association of CENP-E with kinetochores and blocks the metaphase alignment of chromosomes.Proteasome inhibitors and cardiac cell growthInducible cyclic AMP early repressor produces reactivation of latent herpes simplex virus type 1 in neurons in vitroHow dietary arachidonic- and docosahexaenoic- acid rich oils differentially affect the murine hepatic transcriptome.Stress-induced translation of ATF5 mRNA is regulated by the 5'-untranslated region.Transcriptional regulation of the chemokine co-receptor CCR5 by the cAMP/PKA/CREB pathway.Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells.Overexpression of activating transcription factor 5 in human rectal cancer.Up-regulation of activating transcription factor-5 suppresses SAP expression to activate T cells in hemophagocytic syndrome associated with Epstein-Barr virus infection and immune disorders.The transcription factor ATF5: role in neurodevelopment and neural tumors.Translational control by eIF2α in neurons: Beyond the stress response.Ras-induced melanoma transformation is associated with the proteasomal degradation of the transcriptional repressor ICER.(Z)-1,1-Dichloro-2-(4-methoxyphenyl)-3-phenylcyclopropane induces concentration-dependent growth inhibition, apoptosis, and coordinates regulation of apoptotic genes in TRAMP cells.Cdc34-mediated degradation of ATF5 is blocked by cisplatin.Activating Transcription Factor-5 Knockdown Reduces Aggressiveness of Mammary Tumor Cells and Attenuates Mammary Tumor Growth.N-terminal hydrophobic amino acids of activating transcription factor 5 (ATF5) protein confer interleukin 1β (IL-1β)-induced stabilization.Sit4 phosphatase is functionally linked to the ubiquitin-proteasome system.Activating transcription factor 4 overexpression inhibits proliferation and differentiation of mammary epithelium resulting in impaired lactation and accelerated involution.The transcription factor ATF5: role in cellular differentiation, stress responses, and cancer.Differential expression of ubiquitin-conjugating enzyme E2r in the developing ovary and testis of penaeid shrimp Marsupenaeus japonicus.The 5'-untranslated region regulates ATF5 mRNA stability via nonsense-mediated mRNA decay in response to environmental stress.Inactivation of the ubiquitin conjugating enzyme UBE2Q2 causes a prophase arrest and enhanced apoptosis in response to microtubule inhibiting agents.Spermatid nuclear and sperm periaxonemal anomalies in the mouse Ube2b null mutant.
P2860
3a9b612ef84e659b7dc18e9dd58dca5ccf099f2850d907f5596463d316853375faa7b5154c00e2e3533632664abcff8f1a24ba85245ebd20989ce47a7079bf52797c3e5f9877466458e2859c256f3fc17cd8f16dcd4961dcd52ca480dedbd83657a204599c167cea06cc28df9346b390a74baf2414a1fe65df37b21b3a35c4d2e29778ce6102d209bb9ec939e5c6c191d16bf928070604d057b9692f0978f7ab
P248
Q24290903-3FA6C522-E823-45B9-9BC3-4EB51C5F90DAQ24301990-7AF1CF2D-1A71-4AA9-9E85-3F54F8984E74Q24316988-4A6FF8C0-C59F-42C6-A5A8-369FF7685E2AQ24646543-E52CE67A-9AA5-46EF-A52C-C17605979AB6Q24673707-958BA200-9C38-4CD8-AB88-DC1CDA80DE56Q24676092-87C2FCC8-374F-4D94-8E19-D45CF1443A9CQ24802049-841E2685-1FD0-4669-B640-ECB3ACC34F1DQ27934435-BDCF86D7-84C2-4318-8779-F5A11D67211DQ28215703-A2A1D830-595F-4F1E-A17D-1713B27D0E74Q28573772-A242C1CC-7333-4DAB-9256-0C0E5852DFB8Q28577194-87C6A318-EE6F-4302-B6ED-2445754F06C1Q28591285-B9A13D1C-6517-4FEB-8DE5-B3E8259DAF8EQ30307758-FF8F8A3F-1875-4BEE-B82A-0535AF2BF68BQ33554490-3419A590-31DD-4015-9A19-EAA6A2F1D225Q33865985-08B998E9-14C7-44F0-901C-E7B3E96ABB0EQ34681828-C114DEA3-D833-41D7-9DFA-5637A763A17BQ34720944-7121AE2F-9110-4718-AEBD-EE29291E4695Q35148038-60B98884-6F30-405A-BBB0-FC94300D65DAQ35741518-631409A8-2FFC-485C-BE6D-9FBCCE2EF87EQ36230721-2DCA1869-23BF-4CB5-BBE8-078B0FF3A4A7Q36943080-F5C77600-86B5-4486-B759-EDD5F03A8712Q37338389-D144CEF8-45C8-4E1C-8AAF-559918F2EB68Q38781395-21B85F58-46EE-4D5E-AD36-8F1BEDC516D5Q39367185-72902882-8D3C-43DB-A146-E645068F7C64Q39775110-640A73CA-D65B-479A-A960-662A2B889F35Q39985191-6DA7197A-C180-4896-87B5-C195C8F4E392Q41074414-0296F4A2-0220-46BD-A93F-2F9DDD8C2E54Q41954745-6FA7F2CF-33AF-4207-A85B-088ADECDA89DQ42077760-B3897768-FDF9-4FF9-9428-6B9886048123Q44336479-BC5799BD-8049-4FAC-80CE-3B961D938E74Q46003320-2F24FC8D-05EB-4FF9-A558-970C2D1F2796Q46131810-5AC3142F-B006-4E3F-8ECD-EEE4181D7357Q47959334-E50BE66B-44FB-4356-9AEF-F21D6564BEFBQ53556295-653521CF-3B30-4967-8558-29F9C290CB46Q54769784-E2298A15-B494-4C00-B2F0-412E5870D227
P2860
Human Cdc34 and Rad6B ubiquitin-conjugating enzymes target repressors of cyclic AMP-induced transcription for proteolysis
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Human Cdc34 and Rad6B ubiquiti ...... transcription for proteolysis
@ast
Human Cdc34 and Rad6B ubiquiti ...... transcription for proteolysis
@en
Human Cdc34 and Rad6B ubiquiti ...... transcription for proteolysis
@en-gb
Human Cdc34 and Rad6B ubiquiti ...... transcription for proteolysis
@nl
type
label
Human Cdc34 and Rad6B ubiquiti ...... transcription for proteolysis
@ast
Human Cdc34 and Rad6B ubiquiti ...... transcription for proteolysis
@en
Human Cdc34 and Rad6B ubiquiti ...... transcription for proteolysis
@en-gb
Human Cdc34 and Rad6B ubiquiti ...... transcription for proteolysis
@nl
prefLabel
Human Cdc34 and Rad6B ubiquiti ...... transcription for proteolysis
@ast
Human Cdc34 and Rad6B ubiquiti ...... transcription for proteolysis
@en
Human Cdc34 and Rad6B ubiquiti ...... transcription for proteolysis
@en-gb
Human Cdc34 and Rad6B ubiquiti ...... transcription for proteolysis
@nl
P2093
P2860
P921
P356
P1476
Human Cdc34 and Rad6B ubiquiti ...... transcription for proteolysis
@en
P2093
P2860
P304
P356
10.1128/MCB.19.7.5001
P407
P577
1999-07-01T00:00:00Z